Airbus is weighing the sale of some assets to address European Union antitrust concerns over its planned space joint venture with Thales and Leonardo, according to a report from the Financial Times. The move surfaced in discussions with EU competition regulators, who are reviewing the proposed tie-up that would create a major new player in the European space industry.
The three companies announced the merger in October 2025, aiming to combine their space operations into a single entity that could begin operating as early as 2027, pending regulatory approval. The deal is seen as a way to pool resources and compete more effectively against rivals such as SpaceX and other global players in satellite manufacturing and launch services.
Why asset sales matter
When companies propose a merger that could reduce competition in a particular market, regulators often worry that the combined entity will have too much power, potentially leading to higher prices or less innovation. One common remedy is for the merging companies to sell off certain overlapping assets, known as a divestiture, to preserve competition.
According to the Financial Times, Airbus floated the possibility of asset sales during talks with EU competition officials. This is a standard approach in large mergers, as it can help reassure regulators that the deal will not harm consumers or other businesses. The discussions are described as ongoing, with no final decisions made yet. A formal proposal is expected to be submitted to the European Commission, the EU's executive body that oversees antitrust matters.
The exact assets that might be sold have not been disclosed, and it is unclear how much revenue or market share they represent. In similar cases, companies often divest business lines that overlap directly with those of their merger partner, allowing a competitor to acquire them and maintain a competitive balance.
What this means for investors
For everyday investors, the key takeaway is that this merger is not a done deal. Regulatory approval is a significant hurdle, and the process can take months or even years. The fact that Airbus is already discussing remedies suggests that both the company and regulators are taking the competition concerns seriously, which could increase the chances of approval—but it also means the final shape of the deal may look different from the original plan.
If asset sales are required, they could reduce the combined company's scale or profitability, potentially affecting the value of the deal for shareholders. On the other hand, a willingness to make concessions could speed up the approval process, reducing uncertainty for investors in Airbus, Thales, and Leonardo.
Investors should also consider the broader context. The space industry is capital-intensive and increasingly competitive, with private players like SpaceX driving down costs and pushing innovation. A combined European entity could be better positioned to compete, but it also faces the challenge of integrating different corporate cultures and technologies.
For those holding shares in any of the three companies, the next milestones to watch are the formal proposal to the European Commission and any subsequent decisions on remedies. The outcome will likely have a direct impact on the stock prices of all three firms.
Broader market backdrop
The news comes amid a busy period for European corporate activity, with companies across sectors adjusting to shifting economic conditions. While the space merger is a unique deal, it reflects a broader trend of consolidation in industries where scale is seen as essential to compete globally.
Investors have also been watching other sectors, such as consumer spending trends and economic data, for clues about the health of the broader economy. But for now, the focus in the space sector is on how regulators will shape the future of this major European merger.
As the situation develops, investors will be looking for more details on which assets might be sold and what impact that could have on the combined company's financials. Until then, the uncertainty remains a factor for anyone with exposure to these stocks.
